Peptide record

TPDB11682

Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity standard
37 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11682
Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb APD_complete HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 37-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
SLGNFFRKARKKIGEEFKRIVQRIKDFLQHLIPRTEA
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C204H334N62O51
CMWY
RK
4471.28
11.46
11
4
14
+6
2.81
-0.681
87.03
Mammalian: 1.9 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
5
Residue Composition
number
2
A
5
R
1
N
1
D
0
C
3
E
2
Q
2
G
1
H
4
I
3
L
5
K
0
M
4
F
1
P
1
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 5 N: 1 D: 1 C: 0 E: 3 Q: 2 G: 2 H: 1 I: 4 L: 3 K: 5 M: 0 F: 4 P: 1 S: 1 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
37 reviewed residue count
C204H334N62O51 sequence-only estimate (linear, free termini)
4471.28 sequence-only estimate (linear, free termini)
11.46 sequence-only estimate (linear, free termini)
+6 sequence-only estimate (linear, free termini)
2.81 sequence-only estimate (linear, free termini)
-0.681 sequence-only estimate (linear, free termini)
Evidence Records 3 records
Evidence 1 Activity

Activity

55% Hemolysis
Toxicity
10 µM
Hemolytic Cytotoxic
55% Hemolysis | 10 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity. | J Biol Chem | 2006
Evidence 2 Activity

Activity

100% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
100% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity. | J Biol Chem | 2006
Evidence 3 Hemolysis

Source & Reference

APD_complete HemoPI PD_Hemolysis
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.